Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry

  1. Millesimo, M.
  2. Elia, E.
  3. Marengo, G.
  4. De Filippo, O.
  5. Raposeiras-Roubin, S.
  6. Wańha, W.
  7. Abu-Assi, E.
  8. Kinnaird, T.
  9. Ariza-Solé, A.
  10. Liebetrau, C.
  11. Manzano-Fernández, S.
  12. Iannaccone, M.
  13. Henriques, J.P.S.
  14. Templin, C.
  15. Wilton, S.B.
  16. Velicki, L.
  17. Xanthopoulou, I.
  18. Correia, L.
  19. Cerrato, E.
  20. Rognoni, A.
  21. Nuñez-Gil, I.
  22. Song, X.
  23. Kawaji, T.
  24. Quadri, G.
  25. Huczek, Z.
  26. Paz, R.C.
  27. Juanatey, J.R.G.
  28. Nie, S.-P.
  29. Kawashiri, M.-A.
  30. Dominguez-Rodriguez, A.
  31. Conrotto, F.
  32. D’Ascenzo, F.
  33. De Ferrari, G.M.
  34. Show all authors +
Journal:
American Journal of Cardiovascular Drugs

ISSN: 1179-187X

Year of publication: 2023

Volume: 23

Issue: 1

Pages: 77-87

Type: Article

DOI: 10.1007/S40256-022-00554-5 GOOGLE SCHOLAR